Risk factors for adverse drug events: A 10-year analysis

被引:99
|
作者
Evans, RS
Lloyd, JF
Stoddard, GJ
Nebeker, JR
Samore, MH
机构
[1] LDS Hosp, Dept Med Informat, Salt Lake City, UT 84143 USA
[2] Univ Utah, Sch Med, LDS Hosp & Intermt Hlth Care, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Div Clin Epidemiol, Biostat Sect, Salt Lake City, UT 84112 USA
[4] Univ Utah, Sch Med, Div Clin Epidemiol, Salt Lake City, UT 84112 USA
[5] Univ Utah, Sch Med, Dept Med Informat, Salt Lake City, UT USA
关键词
adverse drug events; quality improvement; risk factors;
D O I
10.1345/aph.1E642
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Many adverse drug events (ADEs) are the result of known pharmacologic properties, and some result from medication errors. However, some are the result of patient-specific risk factors. OBJECTIVE: To identify inpatient risk factors for ADEs. METHODS: Conditional logistic regression was used to analyze all pharmacist-verified ADEs by therapeutic class of drugs and severity during a 10-year study period. All inpatients >= 18 years of age from a 520-bed tertiary teaching hospital were included. Each case patient was matched with up to 16 control patients. Odds ratios for patient factors associated with ADEs were calculated from different therapeutic classes of drugs. RESULTS: Odds ratios for numerous risk factors were identified for 4376 ADEs and were found to vary depending on therapeutic classification. The risk factors for the different classifications were grouped by (1) patient characteristics-female (OR 1.5-1.7), age (0.7-0.9), weight (1.2-1.4), creatinine clearance (0.8-4.7), and number of comorbidities (1.1-12.6); (2) drug administration-dosage (1.2-3.7), administration route (1.4-149.9), and number of concomitant drugs (1.2-2.4); and (3) patient type-service (1.2-4.9), nursing division (1.5-3.8), and diagnosis-related group (1.5-5.7). CONCLUSIONS: Some risk factors are consistent for all ADEs and across multiple therapeutic classes of drugs, while others are class specific. High-risk agents should be closely monitored based on patient characteristics (gender, age, weight, creatinine clearance, number of comorbidities) and drug administration (dosage, administration route, number of concomitant drugs).
引用
收藏
页码:1161 / 1168
页数:8
相关论文
共 50 条
  • [41] Prediction of 10-year risk of hard coronary events among Saudi adults based on prevalence of heart disease risk factors
    Soofi, Muhammad Adil
    Youssef, Mostafa Adel
    JOURNAL OF THE SAUDI HEART ASSOCIATION, 2015, 27 (03) : 152 - 159
  • [42] Cardiovascular Risk Factors and Estimated 10-Year Risk of Fatal Cardiovascular Events Using Various Equations in Greeks With Metabolic Syndrome
    Chimonas, Theodoros
    Athyros, Vassilios G.
    Ganotakis, Emmanouel
    Nicolaou, Vassilios
    Panagiotakos, Demosthenes B.
    Mikhailidis, Dimitri P.
    Elisaf, Moses
    ANGIOLOGY, 2010, 61 (01) : 49 - 57
  • [43] Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women
    Song, Yiqing
    Manson, JoAnn E.
    Meigs, James B.
    Ridker, Paul M.
    Buring, Julie E.
    Liu, Simin
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (11): : 1654 - 1658
  • [44] Risk factors for adverse drug events among nursing home residents
    Field, TS
    Gurwitz, JH
    Avorn, J
    McCormick, D
    Jain, S
    Eckler, M
    Benser, M
    Bates, DW
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) : 1629 - 1634
  • [45] A 10-year survey of inflammatory bowel diseases -: drug therapy, costs and adverse reactions
    Blomqvist, P
    Feltelius, N
    Löfberg, R
    Ekbom, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (04) : 475 - 481
  • [46] Spontaneously reported fatal adverse drug reactions: A 10-year survey from Sweden
    Wester, Karin
    Jonsson, Anna K.
    Spigset, Olav
    Hagg, Staffan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S112 - S112
  • [47] Assessing the 10-year risk for atherosclerotic cardiovascular events in cutaneous lupus patients
    Kleitsch, J.
    Zhao, M.
    Pandya, R.
    Lim, D.
    Feng, R.
    Williams, K.
    Werth, V. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S77 - S77
  • [48] Clozapine, relapse and adverse events: 10-year electronic cohort study in Canada: commentary, Kikuchi
    Kikuchi, Yuki
    BRITISH JOURNAL OF PSYCHIATRY, 2025, 226 (01) : 53 - 54
  • [49] Prevalence and Seriousness of Analgesic-Induced Adverse Events in Korea: A 10-Year Nationwide Surveillance
    Choi, Yeo Jin
    Kim, Myoung-Hee
    Chung, Eun Kyoung
    Lee, Jun Kyu
    Yoon, Jimin
    Yug, Ji Seob
    Jang, Dong Kee
    JOURNAL OF PATIENT SAFETY, 2020, 16 (04) : E215 - E224
  • [50] ADVERSE EVENTS ASSOCIATED WITH TESTICULAR PROSTHESIS: A 10-YEAR REVIEW OF THE FDA'S MAUDE DATABASE
    Chiu, Cedrick B.
    Berrios, Susana
    Chughtai, Bilal
    Souders, Colby
    Anger, Jennifer
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1045 - E1046